Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
eli lilly
8
×
biotech
fda
life sciences
national blog main
clinical trials
boston blog main
national top stories
boston top stories
europe blog main
indiana blog main
indiana top stories
abbvie
allergan
amgen
europe top stories
genentech
new york blog main
san francisco blog main
san francisco top stories
avapritinib
blueprint medicines
boston
europe
medullary thyroid cancer
national
new york top stories
non-small cell lung cancer
novartis
pralsetinib
raleigh-durham blog main
raleigh-durham top stories
roche
selpercatinib
thyroid cancer
10x genomics
alkermes
alprazolam
anemia
antibiotic
What
fda
8
×
drug
approval
eli
medicines
new
won
blueprint
cancer
designed
lilly
lilly’s
medicine
migraine
regulatory
ret
treatment
wins
acute
address
addresses
adults
alkermes
allergan
antibody
antipsychotic
approved
approves
august
authorized
bamlanivimab
benefits
bid
bio
biotech
block
boehringer
breakthrough
busy
candidate
Language
unset
8
×
Current search:
fda
×
unset
×
" eli lilly "
×
@bgr.com
3 years ago
FDA just authorized a breakthrough coronavirus drug that’s proven to save lives
@xconomy.com
3 years ago
FDA Panel Vote Weighs in Favor of Alkermes Psyche Drug, With Caveats
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
FDA Rejects Boehringer Ingelheim, Eli Lilly Drug for Type 1 Diabetes
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
4 years ago
FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More